Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 205


Patterns of failure after immunotherapy with checkpoint inhibitors predict durable progression-free survival after local therapy for metastatic melanoma.

Klemen ND, Wang M, Feingold PL, Cooper K, Pavri SN, Han D, Detterbeck FC, Boffa DJ, Khan SA, Olino K, Clune J, Ariyan S, Salem RR, Weiss SA, Kluger HM, Sznol M, Cha C.

J Immunother Cancer. 2019 Jul 24;7(1):196. doi: 10.1186/s40425-019-0672-3.


In silico validation of the indigenous knowledge of the herbal medicines among tribal communities in Sathyamangalam wildlife sanctuary, India.

Chinnasamy P, Arumugam R, Ariyan S.

J Tradit Complement Med. 2018 May 3;9(2):143-155. doi: 10.1016/j.jtcme.2018.01.008. eCollection 2019 Apr.


Nonvisualization of Sentinel Lymph Nodes by Lymphoscintigraphy in Primary Cutaneous Melanoma: Incidence, Risk Factors, and a Review of Management Options.

Pavri SN, Gary C, Martinez RS, Kim S, Han D, Ariyan S, Narayan D.

Plast Reconstr Surg. 2018 Oct;142(4):527e-534e. doi: 10.1097/PRS.0000000000004771.


A Thirty-Year Experience With Head and Neck Flap Reconstruction.

Sun AH, Xu X, Sasaki CT, Ariyan S, Steinbacher DM.

J Craniofac Surg. 2017 Jul;28(5):1354-1361. doi: 10.1097/SCS.0000000000003591.


Interlesional diversity of T cell receptors in melanoma with immune checkpoints enriched in tissue-resident memory T cells.

Boddupalli CS, Bar N, Kadaveru K, Krauthammer M, Pornputtapong N, Mai Z, Ariyan S, Narayan D, Kluger H, Deng Y, Verma R, Das R, Bacchiocchi A, Halaban R, Sznol M, Dhodapkar MV, Dhodapkar KM.

JCI Insight. 2016 Dec 22;1(21):e88955. doi: 10.1172/jci.insight.88955.


Regression in thin melanoma is associated with nodal recurrence after a negative sentinel node biopsy.

Rubinstein JC, Han G, Jackson L, Bulloch K, Ariyan S, Narayan D, Rothberg BG, Han D.

Cancer Med. 2016 Oct;5(10):2832-2840. doi: 10.1002/cam4.922. Epub 2016 Sep 27.


Functional Neck Dissection: The Operative Technique Series.

Patel A, Clune J, Ariyan S.

Plast Reconstr Surg. 2016 Nov;138(5):1084-1086.


The Prognostic Significance of Sentinel Lymph Node Status for Patients with Thick Melanoma.

Bello DM, Han G, Jackson L, Bulloch K, Ariyan S, Narayan D, Rothberg BG, Han D.

Ann Surg Oncol. 2016 Dec;23(Suppl 5):938-945. Epub 2016 Aug 15.


Malignant Melanoma: Beyond the Basics.

Pavri SN, Clune J, Ariyan S, Narayan D.

Plast Reconstr Surg. 2016 Aug;138(2):330e-40e. doi: 10.1097/PRS.0000000000002367. Review.


Intratumoral multinucleated giant cells are not a prognostic pathologic feature in cutaneous melanoma.

Srisuttiyakorn C, Bulloch K, Rodic N, Bosenberg M, Ariyan S, Narayan D, Gould Rothberg BE, Galan A.

J Cutan Pathol. 2016 Oct;43(10):821-9. doi: 10.1111/cup.12750. Epub 2016 Jun 30.


Eruptive melanocytic nevi heralding the diagnosis of metastatic malignant melanoma: A case report.

Kibbi N, Ariyan S, Slogoff F, Lazova R, Choi JN.

JAAD Case Rep. 2015 Mar 6;1(2):74-6. doi: 10.1016/j.jdcr.2015.01.002. eCollection 2015 Mar. No abstract available.


Empowerment over charity: How surgeons turned Armenia's tragedy into opportunity.

Ariyan S.

Bull Am Coll Surg. 2016 Feb;101(2):9-17. No abstract available.


Pedicle versus free flap reconstruction in patients receiving intraoperative brachytherapy.

Geiger EJ, Basques BA, Chang CC, Son Y, Sasaki CT, McGregor A, Ariyan S, Narayan D.

J Plast Surg Hand Surg. 2016 Aug;50(4):227-32. doi: 10.3109/2000656X.2016.1152974. Epub 2016 Mar 16.


Final Results of the Sunbelt Melanoma Trial: A Multi-Institutional Prospective Randomized Phase III Study Evaluating the Role of Adjuvant High-Dose Interferon Alfa-2b and Completion Lymph Node Dissection for Patients Staged by Sentinel Lymph Node Biopsy.

McMasters KM, Egger ME, Edwards MJ, Ross MI, Reintgen DS, Noyes RD, Martin RC 2nd, Goydos JS, Beitsch PD, Urist MM, Ariyan S, Sussman JJ, Davidson BS, Gershenwald JE, Hagendoorn LJ, Stromberg AJ, Scoggins CR.

J Clin Oncol. 2016 Apr 1;34(10):1079-86. doi: 10.1200/JCO.2015.63.3776. Epub 2016 Feb 8.


Benefits and Risks of Prophylaxis for Deep Venous Thrombosis and Pulmonary Embolus in Plastic Surgery: A Systematic Review and Meta-Analysis of Controlled Trials and Consensus Conference.

Pannucci CJ, MacDonald JK, Ariyan S, Gutowski KA, Kerrigan CL, Kim JY, Chung KC.

Plast Reconstr Surg. 2016 Feb;137(2):709-30. doi: 10.1097/01.prs.0000475790.54231.28. Review.


Treatment of in-transit melanoma with intralesional bacillus Calmette-Guérin (BCG) and topical imiquimod 5% cream: a report of 3 cases.

Kibbi N, Ariyan S, Faries M, Choi JN.

J Immunother. 2015 Nov-Dec;38(9):371-5. doi: 10.1097/CJI.0000000000000098.


Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas.

Krauthammer M, Kong Y, Bacchiocchi A, Evans P, Pornputtapong N, Wu C, McCusker JP, Ma S, Cheng E, Straub R, Serin M, Bosenberg M, Ariyan S, Narayan D, Sznol M, Kluger HM, Mane S, Schlessinger J, Lifton RP, Halaban R.

Nat Genet. 2015 Sep;47(9):996-1002. doi: 10.1038/ng.3361. Epub 2015 Jul 27.


Antibiotic prophylaxis for preventing surgical-site infection in plastic surgery: an evidence-based consensus conference statement from the American Association of Plastic Surgeons.

Ariyan S, Martin J, Lal A, Cheng D, Borah GL, Chung KC, Conly J, Havlik R, Lee WP, McGrath MH, Pribaz J, Young VL.

Plast Reconstr Surg. 2015 Jun;135(6):1723-39. doi: 10.1097/PRS.0000000000001265. Review.


Using topical imiquimod for the management of positive in situ margins after melanoma resection.

Pandit AS, Geiger EJ, Ariyan S, Narayan D, Choi JN.

Cancer Med. 2015 Apr;4(4):507-12. doi: 10.1002/cam4.402. Epub 2015 Jan 26.


Comparison of the expression of vimentin and actin in spitz nevi and spitzoid malignant melanomas.

Alomari AK, Klump V, Neumeister V, Ariyan S, Narayan D, Lazova R.

Am J Dermatopathol. 2015 Jan;37(1):46-51. doi: 10.1097/DAD.0000000000000147.


Scalp melanoma and in-transit metastases: a retrospective case-controlled study.

Teng E, Sue GR, Sawh-Martinez R, Nishikawa S, Ariyan S, Natarajan A, Narayan D.

Am Surg. 2014 Dec;80(12):1272-4. No abstract available.


Clinical characteristics associated with Spitz nevi and Spitzoid malignant melanomas: the Yale University Spitzoid Neoplasm Repository experience, 1991 to 2008.

Lott JP, Wititsuwannakul J, Lee JJ, Ariyan S, Narayan D, Kluger HH, Lazova R.

J Am Acad Dermatol. 2014 Dec;71(6):1077-82. doi: 10.1016/j.jaad.2014.08.026. Epub 2014 Oct 11. Erratum in: J Am Acad Dermatol. 2015 Apr;72(4):748.


Management of head and neck melanoma: results of a national survey.

Sawh-Martinez R, Douglas S, Pavri S, Ariyan S, Narayan D.

Ann Plast Surg. 2014 Dec;73 Suppl 2:S175-7. doi: 10.1097/SAP.0000000000000182.


Desmoplastic melanoma: a 12-year experience with sentinel lymph node biopsy.

Broer PN, Walker ME, Goldberg C, Buonocore S, Braddock DT, Lazova R, Narayan D, Ariyan S.

Eur J Surg Oncol. 2013 Jul;39(7):681-5. doi: 10.1016/j.ejso.2013.02.025. Epub 2013 Mar 22.


Use of the external pectoralis myocutaneous major flap in anterior skull base reconstruction.

Kadlub N, Shin JH, Ross DA, Della Torre T, Ansari E, Persing JA, Ariyan S.

Int J Oral Maxillofac Surg. 2013 Apr;42(4):453-7. doi: 10.1016/j.ijom.2012.10.038. Epub 2013 Jan 3.


Integrated analysis of tumor samples sheds light on tumor heterogeneity.

Parisi F, Micsinai M, Strino F, Ariyan S, Narayan D, Bacchiocchi A, Cheng E, Xu F, Li P, Kluger H, Halaban R, Kluger Y.

Yale J Biol Med. 2012 Sep;85(3):347-61. Epub 2012 Sep 25.


A targeted approach to sentinel lymph node biopsies in the parotid region for head and neck melanomas.

Samra S, Sawh-Martinez R, Tom L, Colebunders B, Salameh B, Truini C, Ariyan S, Narayan D.

Ann Plast Surg. 2012 Oct;69(4):415-7. doi: 10.1097/SAP.0b013e31824a21af.


Level I sparing radical neck dissections for cutaneous melanoma in the lymphoscintigram era.

Sawh-Martinez R, Salameh B, Colebunders B, Tom L, Samra S, Truini C, Ariyan S, Narayan D.

Ann Plast Surg. 2012 Oct;69(4):422-4. doi: 10.1097/SAP.0b013e31824b271f.


Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma.

Krauthammer M, Kong Y, Ha BH, Evans P, Bacchiocchi A, McCusker JP, Cheng E, Davis MJ, Goh G, Choi M, Ariyan S, Narayan D, Dutton-Regester K, Capatana A, Holman EC, Bosenberg M, Sznol M, Kluger HM, Brash DE, Stern DF, Materin MA, Lo RS, Mane S, Ma S, Kidd KK, Hayward NK, Lifton RP, Schlessinger J, Boggon TJ, Halaban R.

Nat Genet. 2012 Sep;44(9):1006-14. doi: 10.1038/ng.2359. Epub 2012 Jul 29.


A proposal for the timing of management of patients with melanoma presenting during pregnancy.

Broer N, Buonocore S, Goldberg C, Truini C, Faries MB, Narayan D, Ariyan S.

J Surg Oncol. 2012 Jul 1;106(1):36-40. doi: 10.1002/jso.23035. Epub 2012 Feb 13.


Melanoma brain metastases: is it time to reassess the bias?

Flanigan JC, Jilaveanu LB, Faries M, Sznol M, Ariyan S, Yu JB, Knisely JP, Chiang VL, Kluger HM.

Curr Probl Cancer. 2011 Jul-Aug;35(4):200-10. doi: 10.1016/j.currproblcancer.2011.07.003. No abstract available.


Current surgical treatment in melanoma.

Faries MB, Ariyan S.

Curr Probl Cancer. 2011 Jul-Aug;35(4):173-84. doi: 10.1016/j.currproblcancer.2011.07.002. No abstract available.


A prospective trial on the use of antibiotics in hand surgery.

Patel A, Forte AJ, Ariyan S.

Plast Reconstr Surg. 2011 Jul;128(1):335-6. doi: 10.1097/PRS.0b013e3182173e28. No abstract available.


Detecting copy number status and uncovering subclonal markers in heterogeneous tumor biopsies.

Parisi F, Ariyan S, Narayan D, Bacchiocchi A, Hoyt K, Cheng E, Xu F, Li P, Halaban R, Kluger Y.

BMC Genomics. 2011 May 11;12:230. doi: 10.1186/1471-2164-12-230.


MicroRNA signatures differentiate melanoma subtypes.

Chan E, Patel R, Nallur S, Ratner E, Bacchiocchi A, Hoyt K, Szpakowski S, Godshalk S, Ariyan S, Sznol M, Halaban R, Krauthammer M, Tuck D, Slack FJ, Weidhaas JB.

Cell Cycle. 2011 Jun 1;10(11):1845-52. Epub 2011 Jun 1.


Excising value at a marginal cost: rethinking the management of Basal cell carcinoma.

Patel A, Clune JE, Mody P, Price G, Ariyan S.

Plast Reconstr Surg. 2011 May;127(5):2136-7; author reply 2137. doi: 10.1097/PRS.0b013e31820e9405. No abstract available.


Plasma markers for identifying patients with metastatic melanoma.

Kluger HM, Hoyt K, Bacchiocchi A, Mayer T, Kirsch J, Kluger Y, Sznol M, Ariyan S, Molinaro A, Halaban R.

Clin Cancer Res. 2011 Apr 15;17(8):2417-25. doi: 10.1158/1078-0432.CCR-10-2402. Epub 2011 Apr 12.


Melanoma of the head and neck.

Au A, Ariyan S.

J Craniofac Surg. 2011 Mar;22(2):421-9. doi: 10.1097/SCS.0b013e318207f28b. Review.


The effect of etomidate on adrenal function in critical illness: a systematic review.

Albert SG, Ariyan S, Rather A.

Intensive Care Med. 2011 Jun;37(6):901-10. doi: 10.1007/s00134-011-2160-1. Epub 2011 Mar 4. Review.


A Variant in a MicroRNA complementary site in the 3' UTR of the KIT oncogene increases risk of acral melanoma.

Godshalk SE, Paranjape T, Nallur S, Speed W, Chan E, Molinaro AM, Bacchiocchi A, Hoyt K, Tworkoski K, Stern DF, Sznol M, Ariyan S, Lazova R, Halaban R, Kidd KK, Weidhaas JB, Slack FJ.

Oncogene. 2011 Mar 31;30(13):1542-50. doi: 10.1038/onc.2010.536. Epub 2010 Nov 29.


Management of the difficult sentinel lymph node in patients with primary cutaneous melanoma.

Silverio A, McRae M, Ariyan S, Narayan D.

Ann Plast Surg. 2010 Oct;65(4):418-24. doi: 10.1097/SAP.0b013e3181a42d4a.


Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032.

Rubinstein JC, Sznol M, Pavlick AC, Ariyan S, Cheng E, Bacchiocchi A, Kluger HM, Narayan D, Halaban R.

J Transl Med. 2010 Jul 14;8:67. doi: 10.1186/1479-5876-8-67.


PLX4032, a selective BRAF(V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF melanoma cells.

Halaban R, Zhang W, Bacchiocchi A, Cheng E, Parisi F, Ariyan S, Krauthammer M, McCusker JP, Kluger Y, Sznol M.

Pigment Cell Melanoma Res. 2010 Apr;23(2):190-200. doi: 10.1111/j.1755-148X.2010.00685.x. Epub 2010 Feb 10. Erratum in: Pigment Cell Melanoma Res. 2012 May;25(3):402.


Metachronous primary melanoma and lymphoma.

McIntosh BC, Ariyan S, Esche G, Zelterman D, Narayan D.

Ann Plast Surg. 2010 Feb;64(2):229-32. doi: 10.1097/SAP.0b013e3181a13dbf.


Factors associated with false-negative sentinel lymph node biopsy in melanoma patients.

Scoggins CR, Martin RC, Ross MI, Edwards MJ, Reintgen DS, Urist MM, Gershenwald JE, Sussman JJ, Dirk Noyes R, Goydos JS, Beitsch PD, Ariyan S, Stromberg AJ, Hagendoorn LJ, McMasters KM.

Ann Surg Oncol. 2010 Mar;17(3):709-17. doi: 10.1245/s10434-009-0858-x. Epub 2009 Dec 5.


Melanoma prognostic model using tissue microarrays and genetic algorithms.

Gould Rothberg BE, Berger AJ, Molinaro AM, Subtil A, Krauthammer MO, Camp RL, Bradley WR, Ariyan S, Kluger HM, Rimm DL.

J Clin Oncol. 2009 Dec 1;27(34):5772-80. doi: 10.1200/JCO.2009.22.8239. Epub 2009 Nov 2.


Genome-wide screen of promoter methylation identifies novel markers in melanoma.

Koga Y, Pelizzola M, Cheng E, Krauthammer M, Sznol M, Ariyan S, Narayan D, Molinaro AM, Halaban R, Weissman SM.

Genome Res. 2009 Aug;19(8):1462-70. doi: 10.1101/gr.091447.109. Epub 2009 Jun 2.


Management of the difficult sentinel lymph node in patients with primary cutaneous melanoma.

Silverio AM, McRae MC, Ariyan S, Narayan D.

Ann Plast Surg. 2009 May;62(5):564-9. doi: 10.1097/SAP.0b013e3181a395e2.


Integrative analysis of epigenetic modulation in melanoma cell response to decitabine: clinical implications.

Halaban R, Krauthammer M, Pelizzola M, Cheng E, Kovacs D, Sznol M, Ariyan S, Narayan D, Bacchiocchi A, Molinaro A, Kluger Y, Deng M, Tran N, Zhang W, Picardo M, Enghild JJ.

PLoS One. 2009;4(2):e4563. doi: 10.1371/journal.pone.0004563. Epub 2009 Feb 23.

Supplemental Content

Loading ...
Support Center